Qbtech in a growth investment deal backed by Verdane.

Qbtech, a Stockholm, Sweden-based medical software company developing solutions and products for ADHD, announced getting into an investment agreement to raise a SEK 160 million ($15.4 million) equity round.

The money was raised from the Nordic investors from Verdane, via their equity fund Idun.

Qbtech, founded in 2002 by CEO Carl Reuterskiöld, is a software provider of objective ADHD tests QbTest and QbCheck, working for improving the identification, diagnosis, treatment, and follow-up of patients living with ADHD. The company has operations in 13 countries and has offices in Stockholm, Houston, and London. It produced sales of SEK 35 million ($3.5 million) in 2021.